Brief: NGM Biopharmaceuticals Received Non-Binding Expression Of Interest From Column Group

NGM Biopharmaceuticals

02/01/2024 12:36

Jan 2 (Reuters) - NGM Biopharmaceuticals Inc  NGM.O :
    * CONFIRM RECEIVED NON-BINDING EXPRESSION OF INTEREST ON DEC
28
FROM COLUMN GROUP, CERTAIN AFFILIATED INVESTMENT FUNDS, PERSONS
    * BOARD HAS FORMED SPECIAL COMMITTEE TO CONSIDER EOI AND ANY
OTHER
STRATEGIC ALTERNATIVES THAT MAY BE AVAILABLE TO THE COMPANY
    * TCG CURRENTLY BENEFICIALLY OWNS APPROXIMATELY 26.7% OF
OUTSTANDING SHARES OF NGM BIO'S COMMON STOCK

Source text for Eikon:  ID: 
Further company coverage:  NGM.O 

 ((Reuters.Briefs@thomsonreuters.com;))